GRFS Grifols Sa

$8.55 +0.59%

Data as of Nov 3, 2026 close

Healthcare · Pharmaceutical Preparations

Grifols Sa (GRFS) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $8.55, 13.6% below their 52-week high. Over the past year the stock is down 8.5%.

Market Cap

—

Shares Out

—

EPS (TTM) (per ord. share)

—

P/E (TTM)*

—

P/S Ratio

—

P/B Ratio

—

Dividend / ord. share

—

Dividend Yield

—

52-Week High

$9.90

52-Week Low

$6.96

Volume (venue)

81,508

Avg Vol (3m, venue)

46,671.127

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Grifols Sa reports in EUR: EPS, dividends and financials are shown in EUR as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

+5.29%

+15.30%

+7.75%

+3.32%

YTD

-8.50%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

75.26

SMA (50)

$7.61

SMA (200)

$8.00

Price vs SMA50

+12.43%

Price vs SMA200

+6.89%

ATR (14)

$0.22

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

GRFS vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of Nov 3, 2026 close

1–14 of 14


LLY	Lilly (Eli)	$1.33T	48.07	15.33	31.9%	-0.12%
JNJ	Johnson & Johnson	$640.8B	39.81	6.45	16.2%	-1.76%
ONC	Beone Medicines Ltd.	$524.6B	800.05	85.59	10.7%	-1.72%
ABBV	AbbVie	$503.8B	48.71	7.63	15.7%	-1.30%
MRK	Merck	$356.9B	112.49	5.36	4.8%	-2.57%
ABT	Abbott Laboratories	$190.6B	30.37	4.22	13.9%	-0.78%
PFE	Pfizer	$171.2B	42.46	2.69	6.3%	-2.18%
VRTX	Vertex Pharmaceuticals	$134.7B	33.87	10.40	30.7%	-6.81%
BMY	Bristol Myers Squibb	$126.1B	13.65	2.52	18.5%	-2.09%
REGN	Regeneron Pharmaceuticals	$100.7B	20.91	5.96	28.5%	+1.30%
TEVA	Teva Pharmaceutical Industries Ltd	$48.9B	96.62	2.84	2.9%	+3.00%
ZTS	Zoetis	$34.3B	13.11	3.60	27.5%	-0.18%
RPRX	Royalty Pharma Plc	$29.5B	36.25	11.65	32.1%	-0.26%
ROIV	Roivant Sciences Ltd.	$26.0B	—	3458.17	—	+0.47%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.